Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status.
Mésange P, Bouygues A, Ferrand N, Sabbah M, Escargueil AE, Savina A, Chibaudel B, Tournigand C, André T, de Gramont A, Larsen AK.
Mésange P, et al. Among authors: escargueil ae.
Clin Cancer Res. 2018 Jun 1;24(11):2548-2558. doi: 10.1158/1078-0432.CCR-17-3187. Epub 2018 Feb 28.
Clin Cancer Res. 2018.
PMID: 29490990